These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10632116)
1. Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. Di Rocco A; Werner P Ann Neurol; 2000 Jan; 47(1):136-7. PubMed ID: 10632116 [No Abstract] [Full Text] [Related]
2. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism. St-Hilaire M; Landry E; Lévesque D; Rouillard C Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973 [TBL] [Abstract][Full Text] [Related]
3. Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. Muriel MP; Bernard V; Levey AI; Laribi O; Abrous DN; Agid Y; Bloch B; Hirsch EC Ann Neurol; 1999 Jul; 46(1):103-11. PubMed ID: 10401786 [TBL] [Abstract][Full Text] [Related]
4. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803 [TBL] [Abstract][Full Text] [Related]
5. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. Aubert I; Ghorayeb I; Normand E; Bloch B J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753 [TBL] [Abstract][Full Text] [Related]
6. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277 [TBL] [Abstract][Full Text] [Related]
7. D1 receptor regulation of preprotachykinin-A gene by extracellular signal-regulated kinase pathway in striatal cultures. Sin M; Michelhaugh SK; Bannon MJ Neuroreport; 2008 Jan; 19(2):187-91. PubMed ID: 18185106 [TBL] [Abstract][Full Text] [Related]
8. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Smith Y; Villalba R Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680 [TBL] [Abstract][Full Text] [Related]
9. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. Deng YP; Lei WL; Reiner A J Chem Neuroanat; 2006 Dec; 32(2-4):101-16. PubMed ID: 16914290 [TBL] [Abstract][Full Text] [Related]
10. Dopamine-mediated gene regulation in models of Parkinson's disease. Gerfen CR Ann Neurol; 2000 Apr; 47(4 Suppl 1):S42-50; discussion S50-2. PubMed ID: 10762131 [TBL] [Abstract][Full Text] [Related]
11. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Huot P; Lévesque M; Parent A Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832 [TBL] [Abstract][Full Text] [Related]
12. [Striatal dopamine availability in Parkinson's disease--with reference to the wearing-off phenomenon]. Indo T Rinsho Shinkeigaku; 1984 Oct; 24(10):1008-16. PubMed ID: 6518691 [No Abstract] [Full Text] [Related]
13. Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats. Muriel MP; Orieux G; Hirsch EC Mov Disord; 2002 Nov; 17(6):1174-9. PubMed ID: 12465054 [TBL] [Abstract][Full Text] [Related]
14. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease. Gerfen CR Neuroscientist; 2003 Dec; 9(6):455-62. PubMed ID: 14678578 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA. Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311 [TBL] [Abstract][Full Text] [Related]
16. Expression of D1 but not D2 dopamine receptors in striatal neurons producing neurokinin B in rats. Sonomura T; Nakamura K; Furuta T; Hioki H; Nishi A; Yamanaka A; Uemura M; Kaneko T Eur J Neurosci; 2007 Dec; 26(11):3093-103. PubMed ID: 18028111 [TBL] [Abstract][Full Text] [Related]
17. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163 [TBL] [Abstract][Full Text] [Related]
18. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease. Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic drugs in development for Parkinson's disease. Korczyn AD Adv Neurol; 2003; 91():267-71. PubMed ID: 12442685 [No Abstract] [Full Text] [Related]
20. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons. Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]